Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.
History, Companies & Products
Explore the main themes, entities and connections around SIGA Technologies. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
siga tpoxx drug technologies smallpox antiviral million tecovirimat united states national fda approved health 2022 inc new monkeypox products research
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| SIGA Technologies | Founded | December 28, 1995; 30 years ago (1995-12-28) | 1.00 | infobox |
| SIGA Technologies | Headquarters | New York City, United States | 1.00 | infobox |
| SIGA Technologies | Industry | Healthcare Biotechnology Health security | 1.00 | infobox |
| SIGA Technologies | Key people | Diem Nguyen, Ph.D. (CEO) Dennis E. Hruby, Ph.D. (CSO) | 1.00 | infobox |
| SIGA Technologies | Net income | $69.5 million (2021) | 1.00 | infobox |
| SIGA Technologies | Number of employees | 39 (2022) | 1.00 | infobox |
| SIGA Technologies | Operating income | $89.1 million (2021) | 1.00 | infobox |
| SIGA Technologies | Products | Pharmaceutical agents | 1.00 | infobox |
| SIGA Technologies | Revenue | $133.7 million (2021) | 1.00 | infobox |
| SIGA Technologies | Traded as | Nasdaq: SIGA Russell 2000 Component | 1.00 | infobox |
| SIGA Technologies | Type | Public | 1.00 | infobox |
| SIGA Technologies | Website | siga.com | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.